This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bridges CR . ‘Recirculating cardiac delivery’ method of gene delivery should be called ‘non-recirculating’ method. Gene Therapy 2009; 16: 939–940.
Kaye DM, Preovolos A, Marshall T, Byrne M, Hoshijima M, Hajjar R et al. Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. J Am Coll Cardiol 2007; 50: 253–260.
Byrne MJ, Power JM, Preovolos A, Mariani JA, Hajjar RJ, Kaye DM . Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals. Gene Therapy 2008; 15: 1550–1557.
Davidson MJ, Jones JM, Emani SM, Wilson KH, Jaggers J, Koch WJ et al. Cardiac gene delivery with cardiopulmonary bypass. Circulation 2001; 104: 131–133.
Penny DJ, Smolich JJ . Divergent effects of NO synthase inhibition on systemic and myocardial O2 delivery and consumption during dobutamine infusion in sheep. Pflugers Arch 2002; 443: 601–608.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaye, D., Byrne, M. & Power, J. Reply to Bridges. Gene Ther 17, 565–566 (2010). https://doi.org/10.1038/gt.2009.163
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2009.163
This article is cited by
-
Percutaneous Approaches for Efficient Cardiac Gene Delivery
Journal of Cardiovascular Translational Research (2013)